MedPath

Citicoline

Generic Name
Citicoline
Drug Type
Small Molecule
Chemical Formula
C14H26N4O11P2
CAS Number
987-78-0
Unique Ingredient Identifier
536BQ2JVC7

Overview

Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others.

Background

Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others.

Indication

主要用于急性颅脑外伤和脑手术后的意识障碍,以及脑卒中而致偏瘫的患者;也用于耳鸣及神经性耳聋、急性中毒、感染、大面积脑梗死所致的昏迷和意识障碍、帕金森病、急性胰腺炎;对缺血性脑血管病和血管性痴呆也有一定疗效,但对颅内出血引起的意识障碍效果较差。

Associated Conditions

  • Degenerative Brain Disorder
  • Parkinsonian Syndromes

Clinical Trials

Phase 4
Completed
Posted: 2014/09/25
Sponsor:
Fengtian Hospital
Phase 4
Completed
Posted: 2014/02/28

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath